Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancing SARS-CoV-2 Rapid Testing Acceptance in Latinx Communities

NCT05910879 is registered in ClinicalTrials.gov with University of Oregon as lead sponsor.

NCT NCT05910879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05910879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancing SARS-CoV-2 Rapid Testing Acceptance in Latinx Communities
Lead sponsor
University of Oregon
Phase
Not applicable
Overall status
Completed
Start date
April 22, 2023
Completion date
February 28, 2025
Enrollment
625 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

health behavior, health care utilization, vaccine hesitancy